Stefano Lancellotti, PhD

Biologist Health Manager
Fondazione Policlinico Universitario A. Gemelli, IRCCS, Center for Hemorrhagic and Thrombotic Diseases and Haemophilia Center, Rome, Italy

Lancellotti Stefano (phD), “Osteoclast role in Haemophilic Bone disease”. Haemostasis and Thrombosis Center of Foundation “A. Gemelli” Hospital IRCCS of Rome, Italy. He has been working for over 10 years in the field of hemostasis and thrombosis. He earned a PhD in Pathophysiology and Pharmacology of Hemostasis and Thrombosis (2007-2010 Catholic University of Sacred Heart in Rome ) and a specialization in Clinical Biochemistry (2006-2007 and 2010-2013 Catholic University of Sacred Heart in Rome)
Since 2021, he is the Lazio regional contact person for the Italian Society for the Study of Haemostasis and Thrombosis (SISET).

Presentation(s):

• OC 20.3 - Osteoclast role in Haemophilic Bone disease

  Sunday, July 10, 2022
  11:15 AM – 11:30 AM

• PB0180 - Laboratory evaluation of extendend-half-life recombinant FVIII products (EHL-FVIIIs): one stage coagulation assay or chromogenic assay?

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0432 - The ADAMTS-13 / von Willebrand factor (VWF) ratio as a prognostic biomarker for the development of portal vein thrombosis (PVT) in patients with compensated cirrhosis.

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0804 - A new type 1 von Willebrand Disease (VWD) characterized by increased clearance of von Willebrand Factor (VWF) due to the heterozygous p.P1127S mutation: clinical phenotype and pathogenic mechanisms.

  Monday, July 11, 2022
  6:30 PM – 7:30 PM